The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up

M. Lebwohl, A. Deodhar, C. E.M. Griffiths, M. A. Menter, D. Poddubnyy, W. Bao, V. Jehl, K. Marfo, P. Primatesta, A. Shete, V. Trivedi, P. J. Mease

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'The risk of malignancy in patients with secukinumab-treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow-up'. Together they form a unique fingerprint.

Medicine & Life Sciences